golimumab

Ligand id: 6776

Name: golimumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: golimumab

No information available.
Summary of Clinical Use
Used in adults with various inflammatory conditions [3] e.g. moderate to severe active rheumatoid arthritis [1], active psoriatic arthritis, active ankylosing spondylitis and moderate to severe ulcerative colitis.
Mechanism Of Action and Pharmacodynamic Effects
Anti-TNFα monoclonal antibody which binds and neutralises soluble and membrane human TNFα, a pro-inflammatory cytokine associated with chronic inflammation.
External links